Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||
| Net Income | N/A | -32,475 | -20,424 |
| Depreciation Amortization | N/A | 3,309 | 755 |
| Other Working Capital | N/A | -1,648 | 104 |
| Other Operating Activity | 0 | 447 | -376 |
| Operating Cash Flow | $N/A | $-30,367 | $-19,941 |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -12,169 | -8,312 |
| Other Investing Activity | 0 | -2,229 | 14,405 |
| Investing Cash Flow | $N/A | $-14,398 | $6,093 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 115,933 | 58,148 |
| Financing Cash Flow | $N/A | $115,933 | $58,148 |
| Exchange Rate Effect | N/A | -3,390 | -90 |
| Beginning Cash Position | N/A | 47,825 | 1,751 |
| End Cash Position | N/A | 115,603 | 45,961 |
| Net Cash Flow | $N/A | $67,778 | $44,210 |
| Free Cash Flow | |||
| Operating Cash Flow | N/A | -30,367 | -19,941 |
| Free Cash Flow | 0 | -30,367 | -19,941 |